Home › NDC Lookup › RxCUI directory › RxCUI 1049670

24 HR pseudoephedrine hydrochloride 240 MG Extended Release Oral Tablet — RxCUI 1049670

RxNorm drug concept · Semantic clinical drug
RxCUI 1049670 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1049670
Official name24 HR pseudoephedrine hydrochloride 240 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspseudoephedrine HCl 240 MG 24HR Extended Release Oral Tablet
FDA products mapped2
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pseudoephedrine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It temporarily relieves nasal congestion from the common cold, hay fever or other upper respiratory allergies. Many products also relieve sinus congestion and pressure.
  • It depends on the product. Regular tablets and softgels are usually taken every 4 to 6 hours, while 12-hour extended-release tablets are taken every 12 hours. Check your box for th...
  • No. Swallow them whole. Don't divide, crush, chew or dissolve them. Seeing part of the tablet in your stool can happen and is normal.
  • Can I crush or chew the extended-release tablets?
📖 Read our full Pseudoephedrine guide →

🕸️ Concept Web — How 24 HR pseudoephedrine hydrochloride 240 MG Exten... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR pseudoephedrine hydrochloride 240 MG Extended Release Oral Tablet RxCUI 1049670

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Pseudoephedrine 8896
    • Pseudoephedrine hydrochloride 91168
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Sudafed 203302
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Pseudoephedrine Extended Release Oral Tablet 373674
    • Pseudoephedrine hydrochloride Extended Release Oral Tablet 2647586
    • Pseudoephedrine Oral Product 1163567
    • Pseudoephedrine Pill 1163568
    • Pseudoephedrine hydrochloride Oral Product 2662900
    • Pseudoephedrine hydrochloride Pill 2662822
    • Pseudoephedrine Extended Release Oral Tablet [Sudafed] 603554
    • Pseudoephedrine hydrochloride Extended Release Oral Tablet [Sudafed] 2656796
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Pseudoephedrine hydrochloride 240 MG 997414
    • 24 HR pseudoephedrine hydrochloride 240 MG Extended Release Oral Tablet [Sudafed] 1049672
    • Pseudoephedrine hydrochloride 240 MG [Sudafed] 1049671

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Pseudoephedrine hydrochloride 240 MG SCDC · 997414
  • Pseudoephedrine Extended Release Oral Tablet SCDF · 373674
  • Pseudoephedrine hydrochloride Extended Release Oral Tablet SCDFP · 2647586
  • Pseudoephedrine Oral Product SCDG · 1163567
  • Pseudoephedrine Pill SCDG · 1163568
  • Pseudoephedrine hydrochloride Oral Product SCDGP · 2662900
  • Pseudoephedrine hydrochloride Pill SCDGP · 2662822

Brand-Name Concepts

  • 24 HR pseudoephedrine hydrochloride 240 MG Extended Release Oral Tablet [Sudafed] SBD · 1049672
  • Pseudoephedrine hydrochloride 240 MG [Sudafed] SBDC · 1049671
  • Pseudoephedrine Extended Release Oral Tablet [Sudafed] SBDF · 603554
  • Pseudoephedrine hydrochloride Extended Release Oral Tablet [Sudafed] SBDFP · 2656796
  • Sudafed Oral Product SBDG · 1180817
  • Sudafed Pill SBDG · 1181395
  • Sudafed BN · 203302

📦 FDA Products & Package NDCs

2 products · 3 package NDCs
3 package NDCs map to RxCUI 1049670 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00363-6611-10 1 BLISTER PACK in 1 CARTON (0363-6611-10) / 10 TABLET, EXTE... Pseudoephedrine Hydrochloride WALGREEN CO. 2026-01-30
58602-0884-27 1 BLISTER PACK in 1 CARTON (58602-884-27) / 10 TABLET, EXTE... Pseudoephedrine Hydrochloride Aurohealth LLC 2025-12-29
58602-0884-58 2 BLISTER PACK in 1 CARTON (58602-884-58) / 5 TABLET, EXTEN... Pseudoephedrine Hydrochloride Aurohealth LLC 2025-12-29
Observed labelers: Aurohealth LLC (2) · WALGREEN CO. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.